By 2026, the agency will gain the power to start negotiating costs for pharmaceuticals and its beneficiaries’ out-of-pocket prescription costs will be limited to $2,000.
Allison Busemeyer
Posted inArts & Entertainment
Academy CEO Bill Kramer looks to future of Oscars
He’s especially ready to ‘move forward’ from the slap.
advertisement
Posted inBusiness
SEC questions Twitter on how it counts fake accounts
Elon Musk raised the issue as grounds to back out of a deal to buy the company for $44 billion.
Posted inBusiness
Peloton to sell bikes on Amazon in bid to reverse slump
The collaboration is the company’s first with another retailer.
Posted inNation & World
Fleet of hydrogen passenger trains begins service in Germany
They will save more than 422,000 gallons of diesel fuel a year.
Posted inBusiness, Nation & World
Trump staffers pushed unproven COVID treatment at FDA
But there’s no evidence that White House efforts ultimately changed the agency’s decisions on hydroxychloroquine or any other therapies.
Posted inBusiness, Nation & World
‘Pre-bunking’ shows promise in fight against misinformation
Google plans to roll out a series of videos soon in Eastern Europe.
Posted inBusiness
Stocks edge higher as Wall Street waits for Fed speech
Jerome Powell will give a speech Friday at an annual economic conference.
Posted inBusiness, Nation & World
Pfizer COVID pill shows little, no benefit in younger adults
But researchers find that Paxlovid reduced hospitalizations among people 65 and older by roughly 75 percent.
Posted inArts & Entertainment
Paul Newman’s daughters sue late actor’s charity foundation
They allege Newman’s Own has improperly cut its mandated contributions to their charities from $400,000 apiece per year to $200,000 each annually.